C12N 2500/62
Dmso
C12N2500/62 (Dmso) appears on 76 US grants and 152 published applications in this corpus.
Search patents in C12N- Granted patents
- 76
- Published applications
- 152
- Assignees
- 124
- Inventors
- 347
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 8 |
| 2003 | 2 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 4 |
| 2006 | 2 | 6 |
| 2007 | 1 | 2 |
| 2008 | 2 | 3 |
| 2009 | 2 | 8 |
| 2010 | 5 | 6 |
| 2011 | 1 | 1 |
| 2012 | 5 | 3 |
| 2013 | 2 | 2 |
| 2014 | 2 | 7 |
| 2015 | 5 | 7 |
| 2016 | 5 | 7 |
| 2017 | 5 | 10 |
| 2018 | 5 | 8 |
| 2019 | 6 | 6 |
| 2020 | 3 | 6 |
| 2021 | 6 | 6 |
| 2022 | 4 | 14 |
| 2023 | 3 | 10 |
| 2024 | 2 | 9 |
| 2025 | 6 | 10 |
| 2026 | 2 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Medium composition for culturing porcine pluripotent stem cells28 Jul 2026US 12,692,477 B2Space F Corp.
- Cell preservation method30 Jun 2026US 12,667,099 B2Cell Exosome Therapeutics Inc.
- Methods for the production of hepatocytes9 Dec 2025US 12,492,380 B2FUJIFILM Cellular Dynamics, Inc.
- Clinical gene signature-based human cell culture model and uses thereof25 Nov 2025US 12,480,096 B2Icahn School of Medicine at Mount Sinai
- Cell bank of high concentration adipose-derived stem cell composition and related methods7 Oct 2025US 12,433,916 B2Rigshospitalet
- Role of hepatocyte-derived extracellular matrix and coagulation factors for the fate restoration and maintenance of human hepatocytes20 Aug 2026US 2026/0242739 A1Phoenixbio Co., Ltd.
- Tumor storage and cell culture compositions13 Aug 2026US 2026/0234568 A1Iovance Biotherapeutics, Inc.
- High-performance mature intestinal organoid regenerative therapeutic agent derived from pluripotent stem cells16 Apr 2026US 2026/0102434 A1Korea Research Institute of Bioscience and Biotechnology
- Methods for Improving Sperm Function and Fertilizing Ability for Assisted Reproduction Techniques26 Feb 2026US 2026/0055364 A1Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet)
- Stem cell therapy based on adipose-derived stem cells8 Jan 2026US 2026/0007702 A1Rigshospitalet
Most cited
By later US patents
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006
- Conditioned media for propagating human pluripotent stem cells145US 6,642,048 B2Geron Corporation · 2003
- cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells69US 6,667,176 B1Geron Corporation · 2003
- Methods of cell culture59US 9,217,168 B2Momenta Pharmaceuticals, Inc. · 2015